A Long-term Study of AK102 in Patients With Hypercholesterolemia

NCT04173403 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

796

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: 450mg AK102
DRUG: 300mg AK102
DRUG: 150mg AK102
DRUG: Statins and/or Ezetimibe

Sponsor

Akeso

Collaborators

[object Object]